 |
Dr. Kang Jaw-Jou
Director General
Taiwan Food and Drug Administration, Department of Health |
Kenneth Hartigan Go
Director General
Food and Drug Administration, Philippines |
Pathom Sawanpanyalert
Deputy Secretary General
Food and Drug Administration of Thailand, Ministry of Public Health |
Melody Martinez Zamudio
Food-Drug Regulation Officer IV, OIC – Licensing and Registration Division
Center for Drug Regulation and Research, Food and Drug Administration, Philippines |
Prof. Andrea Laslop
Head of Scientific Office,
AGES PharmMed, Austria and Austrian
member at CHMP (Committee for Human Medicinal Products) at
EMA (European Medicines Agency) |
Korean Food & Drug Administration |
-
Dr. Victoria Elegant, Vice-President, Medical, Clinical & Regulatory Affairs, Asia-Pacific, Baxter Healthcare, China
-
Lee So Jeong, Head of Regulatory, GlaxoSmithKline, Korea
-
Ari Fujishiro, Associate Director, Regulatory Affairs Group, Asia Development Department, Daiichi Sankyo, Japan
-
Akio Uemura, PhD, Director and Head, Regulatory Affairs, Allergan, Japan
-
Ng Cheng Tiang, Director – Regulatory, Teva Pharmaceutical Industries, Singapore
-
Woody Tan, Director, Regulatory Affairs (J-APAC), Genzyme-Sanofi, Singapore
-
Shell Li, Head of Clinical Research, Boehringer Ingelheim, China
|
-
Jacqueline Mao Yun, M.D., MBA., Director – SSRM (Safety Surveillance and Risk Management), Pfizer, China
-
Lin Hong, PhD, Associate Director, Regulatory Affairs, Asia Pacific Russia CIS (APAC)
-
Established Pharmaceuticals, Abbott, USA
-
Jin Shun, Associate Director, Regulatory Affairs, Takeda Development Center (Asia), Singapore
-
Dr. Bobby George, Assistant Vice President and Head Regulatory Affairs, Reliance Life Sciences., India
-
Dr. Yin Qiman, Regulatory Affairs Director – China, Medtronic, China
|
|
|
|
|
